Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
暂无分享,去创建一个
M. Busquets | J. Estelrich | M. Sánchez-Martín | Joan Estelrich | María Jesús Sánchez-Martín | Maria Antònia Busquets | M. Sanchez-Martin
[1] R. Bryant,et al. Translational dynamics of water at the phospholipid interface. , 2013, The journal of physical chemistry. B.
[2] M. Bawendi,et al. Renal clearance of quantum dots , 2007, Nature Biotechnology.
[3] K. Nicolay,et al. Relaxivity of liposomal paramagnetic MRI contrast agents , 2005, Magnetic Resonance Materials in Physics, Biology and Medicine.
[4] V. Torchilin. Liposomes as delivery agents for medical imaging. , 1996, Molecular medicine today.
[5] Mingwu Shen,et al. Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging. , 2014, Biomaterials.
[6] Ajay Kumar Gupta,et al. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.
[7] Xiaolian Sun,et al. Monodisperse magnetic nanoparticles for theranostic applications. , 2011, Accounts of chemical research.
[8] Sophie Laurent,et al. Classification and basic properties of contrast agents for magnetic resonance imaging. , 2009, Contrast media & molecular imaging.
[9] K. Nicolay,et al. Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis. , 2006, Bioconjugate chemistry.
[10] R. Lauffer,et al. Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.
[11] Peter Caravan,et al. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. , 2006, Chemical Society reviews.
[12] E. E. Carpenter,et al. Enhanced ferrite nanoparticles as MRI contrast agents , 2007 .
[13] Bernhard Gleich,et al. Magnetic Nanoparticles in Magnetic Resonance Imaging and Diagnostics , 2012, Pharmaceutical Research.
[14] Jinyoung Hwang,et al. Bioinspired synthesis and characterization of gadolinium-labeled magnetite nanoparticles for dual contrast t1- and T2-weighted magnetic resonance imaging. , 2010, Bioconjugate chemistry.
[15] Jinwoo Cheon,et al. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. , 2005, Journal of the American Chemical Society.
[16] S. Soenen,et al. Magnetoliposomes: versatile innovative nanocolloids for use in biotechnology and biomedicine. , 2009, Nanomedicine.
[17] J. Estelrich,et al. External magnetic field-induced selective biodistribution of magnetoliposomes in mice , 2012, Nanoscale Research Letters.
[18] Philippe Robert,et al. Recent advances in iron oxide nanocrystal technology for medical imaging. , 2006, Advanced drug delivery reviews.
[19] Sungho Jin,et al. Magnetic nanoparticles for theragnostics. , 2009, Advanced drug delivery reviews.
[20] S. Mann,et al. Formation of iron oxides in unilamellar vesicles , 1988 .
[21] Matthias Stuber,et al. Positive contrast visualization of iron oxide‐labeled stem cells using inversion‐recovery with ON‐resonant water suppression (IRON) , 2007, Magnetic resonance in medicine.
[22] Zahi A Fayad,et al. Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. , 2004, Journal of the American Chemical Society.
[23] Gang Bao,et al. Coating thickness of magnetic iron oxide nanoparticles affects R2 relaxivity , 2007, Journal of magnetic resonance imaging : JMRI.
[24] J. Cheon,et al. Theranostic magnetic nanoparticles. , 2011, Accounts of chemical research.
[25] Mingwu Shen,et al. Hyaluronic Acid-Modified Magnetic Iron Oxide Nanoparticles for MR Imaging of Surgically Induced Endometriosis Model in Rats , 2014, PloS one.
[26] W. Perman,et al. Evaluation of two new gadolinium chelates as contrast agents for MRI. , 1992, Magnetic resonance imaging.
[27] Xing-jie Liang,et al. Biomedical nanomaterials for imaging-guided cancer therapy. , 2012, Nanoscale.
[28] Angelique Louie,et al. Multimodality imaging probes: design and challenges. , 2010, Chemical reviews.
[29] Yongmin Chang,et al. Blood‐Pool and Targeting MRI Contrast Agents: From Gd‐Chelates to Gd‐Nanoparticles , 2012 .
[30] John M Pauly,et al. Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles , 2005, Magnetic resonance in medicine.
[31] Shelton D Caruthers,et al. Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI , 2004, Magnetic resonance in medicine.
[32] Yun Sun,et al. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles. , 2011, Biomaterials.
[33] S. Neubauer,et al. Magnetic Resonance Imaging of Endothelial Adhesion Molecules in Mouse Atherosclerosis Using Dual-Targeted Microparticles of Iron Oxide , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[34] M. Brechbiel,et al. 3D‐micro‐MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties , 2001, Magnetic resonance in medicine.
[35] Enzo Terreno,et al. Challenges for molecular magnetic resonance imaging. , 2010, Chemical reviews.
[36] S. Veintemillas-Verdaguer,et al. Comparative analysis of the 1H NMR relaxation enhancement produced by iron oxide and core-shell iron-iron oxide nanoparticles. , 2007, Magnetic resonance imaging.
[37] H. Shokrollahi,et al. Structure, synthetic methods, magnetic properties and biomedical applications of ferrofluids. , 2013, Materials science & engineering. C, Materials for biological applications.
[38] K J Wolf,et al. MR angiography with superparamagnetic iron oxide: feasibility study. , 1999, Radiology.
[39] Linfeng Zheng,et al. Facile hydrothermal synthesis and surface functionalization of polyethyleneimine-coated iron oxide nanoparticles for biomedical applications. , 2013, ACS applied materials & interfaces.
[40] M. Guéron,et al. Nuclear relaxation in macromolecules by paramagnetic ions: a novel mechanism , 1975 .
[41] Forrest M Kievit,et al. Magnetite Nanoparticles for Medical MR Imaging. , 2011, Materials today.
[42] Valérie Cabuil,et al. Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging. , 2005, Journal of the American Chemical Society.
[43] K. Suhling,et al. Gd-containing conjugated polymer nanoparticles: bimodal nanoparticles for fluorescence and MRI imaging. , 2014, Nanoscale.
[44] D. Forge,et al. Improved Stability and Relaxivity of a Commercial Magnetic Ferrofluid , 2013 .
[45] Taeghwan Hyeon,et al. Inorganic Nanoparticles for MRI Contrast Agents , 2009 .
[46] Ting Song,et al. A review of imaging techniques for systems biology , 2008, BMC Systems Biology.
[47] E. Unger,et al. The effect of lipid composition on the relaxivity of Gd-DTPA entrapped in lipid vesicles of defined size. , 1990, Biochimica et biophysica acta.
[48] G. Tendeloo,et al. Surfactant Effects on the Structural and Magnetic Properties of Iron Oxide Nanoparticles , 2014 .
[49] Jurgen E Schneider,et al. In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide , 2007, Nature Medicine.
[50] C. Diwoky,et al. Ultrasmall superparamagnetic iron oxide (USPIO)-based liposomes as magnetic resonance imaging probes , 2012, International journal of nanomedicine.
[51] J. Estelrich,et al. Magnetoliposomes prepared by reverse-phase followed by sequential extrusion: characterization and possibilities in the treatment of inflammation. , 2011, International journal of pharmaceutics.
[52] P. Choyke,et al. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. , 2008, Nanomedicine.
[53] Boguslaw Tomanek,et al. NaDyF4 Nanoparticles as T2 Contrast Agents for Ultrahigh Field Magnetic Resonance Imaging. , 2012, The journal of physical chemistry letters.
[54] S. Caruthers,et al. Conquering the dark side: colloidal iron oxide nanoparticles. , 2009, ACS nano.
[55] B. Hamm. Iron-oxide-enhanced MR lymphography: just a new toy or a breakthrough? , 2002, European Radiology.
[56] Philippe Pouliot,et al. Superparamagnetic iron oxide based nanoprobes for imaging and theranostics. , 2013, Advances in colloid and interface science.
[57] Jesse V Jokerst,et al. Molecular imaging with theranostic nanoparticles. , 2011, Accounts of chemical research.
[58] S. Laurent,et al. Structure, synthesis and characterization of contrast agents for magnetic resonance molecular imaging , 2007 .
[59] Chenjie Xu,et al. Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin alpha(v)beta3-rich tumor cells. , 2008, Journal of the American Chemical Society.
[60] Anna Roig,et al. Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging. , 2007, Langmuir : the ACS journal of surfaces and colloids.
[61] Hui Mao,et al. Improving the Magnetic Resonance Imaging Contrast and Detection Methods with Engineered Magnetic Nanoparticles , 2012, Theranostics.
[62] Yongmin Chang,et al. Water‐Soluble Ultra Small Paramagnetic or Superparamagnetic Metal Oxide Nanoparticles for Molecular MR Imaging , 2009 .
[63] Yan Zhang,et al. Single-Phase Dy2O3:Tb3+ Nanocrystals as Dual-Modal Contrast Agent for High Field Magnetic Resonance and Optical Imaging , 2011 .
[64] Hak Soo Choi,et al. Renal Clearance of Nanoparticles , 2009 .
[65] David A. Cheresh,et al. Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.
[66] P. Winter,et al. Improved Paramagnetic Chelate for Molecular Imaging with MRI , 2005 .
[67] Yanjing Chen,et al. Controlled release from bilayer-decorated magnetoliposomes via electromagnetic heating. , 2010, ACS nano.
[68] A. Sherry,et al. A responsive europium(III) chelate that provides a direct readout of pH by MRI. , 2010, Journal of the American Chemical Society.
[69] S. Laurent,et al. Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics. , 2011, Nanomedicine.
[70] S. Gambhir,et al. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. , 2003, Genes & development.
[71] S. Soenen,et al. Surface functionalization of magnetoliposomes in view of improving iron oxide-based magnetic resonance imaging contrast agents: anchoring of gadolinium ions to a lipophilic chelate. , 2007, Analytical biochemistry.
[72] Sanjiv S Gambhir,et al. A molecular imaging primer: modalities, imaging agents, and applications. , 2012, Physiological reviews.
[73] Minutes,et al. MOLECULAR IMAGING IN DRUG DISCOVERY AND DEVELOPMENT , 2003 .
[74] S. Soenen,et al. Complexation of gadolinium(III) ions on top of nanometre-sized magnetoliposomes , 2007 .
[75] R. Brooks,et al. Dysprosium-DOTA-PAMAM dendrimers as macromolecular T2 contrast agents. Preparation and relaxometry. , 1998, Investigative radiology.
[76] R. Raghavan,et al. Long-term safety of combined intracerebral delivery of free gadolinium and targeted chemotherapeutic agent PRX321 , 2010, Neurological research.
[77] Enzo Terreno,et al. Highly sensitive MRI chemical exchange saturation transfer agents using liposomes. , 2005, Angewandte Chemie.
[78] R. Weissleder,et al. Imaging in the era of molecular oncology , 2008, Nature.
[79] P. Cullis,et al. Liposomal Gd-DTPA: effect of encapsulation on enhancement of hepatoma model by MRI. , 1989, Magnetic resonance imaging.
[80] M. de Cuyper,et al. Magnetoliposomes , 1988, European Biophysics Journal.
[81] Raimon Sabaté,et al. Preparation and characterization of extruded magnetoliposomes. , 2008, International journal of pharmaceutics.
[82] M. Port,et al. Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents , 2007, International journal of nanomedicine.
[83] H. Maeda,et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[84] T. R. Pisanic,et al. Intracellular nanoparticle coating stability determines nanoparticle diagnostics efficacy and cell functionality. , 2010, Small.
[85] Hui Mao,et al. Metallic iron nanoparticles for MRI contrast enhancement and local hyperthermia. , 2008, Small.
[86] A. Roch,et al. Magnetic resonance relaxation properties of superparamagnetic particles. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[87] Yongmin Chang,et al. Highly water-dispersible PEG surface modified ultra small superparamagnetic iron oxide nanoparticles useful for target-specific biomedical applications , 2008, Nanotechnology.
[88] Ralph Weissleder,et al. Molecular Imaging: Principles and Practice , 2011, The Journal of Nuclear Medicine.
[89] Jeff W M Bulte,et al. In vivo MRI cell tracking: clinical studies. , 2009, AJR. American journal of roentgenology.
[90] Andrew D. Miller,et al. Paramagnetic Liposome Nanoparticles for Cellular and Tumour Imaging , 2010, International journal of molecular sciences.
[91] É. Duguet,et al. Magnetic nanoparticle design for medical diagnosis and therapy , 2004 .
[92] M. Olschewski,et al. Magnetic Resonance Imaging Contrast Agent Targeted Toward Activated Platelets Allows In Vivo Detection of Thrombosis and Monitoring of Thrombolysis , 2008, Circulation.
[93] Xiaoping Hu,et al. Long‐circulating liposomal contrast agents for magnetic resonance imaging , 2006, Magnetic resonance in medicine.
[94] Xiaoxia Du,et al. Water-soluble superparamagnetic manganese ferrite nanoparticles for magnetic resonance imaging. , 2010, Biomaterials.
[95] R. Müller,et al. A Novel Formulation for Superparamagnetic Iron Oxide (SPIO) Particles Enhancing MR Lymphography: Comparison of Physicochemical Properties and The In Vivo Behaviour , 2002, Journal of drug targeting.
[96] Eung Yeop Kim,et al. Self-confirming "AND" logic nanoparticles for fault-free MRI. , 2010, Journal of the American Chemical Society.
[97] T. Meade,et al. High-performance nanostructured MR contrast probes. , 2010, Nanoscale.
[98] J. Lewin,et al. A new type of susceptibility-artefact-based magnetic resonance angiography: intra-arterial injection of superparamagnetic iron oxide particles (SPIO) A Resovist in combination with TrueFisp imaging: a feasibility study. , 2006, Contrast media & molecular imaging.
[99] S. Cherry. Multimodality in vivo imaging systems: twice the power or double the trouble? , 2006, Annual review of biomedical engineering.
[100] Jeff W M Bulte,et al. Iron oxide MR contrast agents for molecular and cellular imaging , 2004, NMR in biomedicine.
[101] K. Krishnan. Biomedical Nanomagnetics: A Spin Through Possibilities in Imaging, Diagnostics, and Therapy , 2010, IEEE Transactions on Magnetics.
[102] Jinwoo Cheon,et al. Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles. , 2009, Angewandte Chemie.